Global ELISA Workstation Market 2018-2022 - Emergence of Pandemics like Zika Virus to Drive Growth - Technavio
Sep. 13, 2018
LONDON--(BUSINESS WIRE)--Sep 13, 2018--The global ELISA workstation market 2018-2022 is expected to post a CAGR of more than 5% during the forecast period, according to the latest market research report by .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180913005413/en/
Technavio has published a new market research report on the global ELISA workstation market for the period 2018-2022. (Photo: Business Wire)
A key factor driving the growth of the market is the growing incidence of chronic diseases. Chronic diseases and conditions such as stroke, cancer, arthritis, and thyroid imbalances are easily diagnosed with the help of ELISA. The ELISA test helps the doctors to assess the severity of disease, estimate the patient’s prognosis, monitor the course of its progression, stability, or resolution, detect a relapse, select drugs, or adjust therapy.
This market research report on the also provides an analysis of the most important trends expected to impact the market outlook during the forecast period. Technavio classifies an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.
In this report, Technavio highlights the emergence of new disease targets as one of the key emerging trends in the global ELISA workstation market:
Global ELISA workstation market: Emergence of new disease targets
Clinical laboratories contribute significantly to the screening, diagnosis, and monitoring of major health conditions. Advances in ELISA testing has led to the increased detection of various conditions in the fields of microbiology and oncology, which have become high profile target areas for new diagnostic and testing strategies. This trend is expected to continue over the forecast period.
“The emergence of different pandemic disease threats such as Zika Virus has created an opportunity for speedy approvals on related test devices. Such pandemics require rapid and accurate diagnostic procedures like ELISA for identification,” says a senior analyst at Technavio for research on life science research tools.
Global ELISA workstation market: Segmentation analysis
This market research report segments the global ELISA workstation market by end-user (healthcare centers and research laboratories and academic institutes) and geographical regions (APAC, EMEA, and the Americas).
The Americas led the market in 2017 with a market share of more than 45%, followed by APAC and EMEA respectively. The market in the region is driven by factors such as the increase in the incidence of infectious diseases that require ELISA technique to detect as well as diagnose various chronic diseases such as diabetes, arthritis, and cardiovascular diseases. Further, the presence of sophisticated infrastructure and growing R&D activities also drive the demand for ELISA workstations market in the Americas.
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Market LandscapeMarket ecosystem Market characteristics Market segmentation analysis
Market SizingMarket definition Market size and forecast
Five Forces Analysis
Geographical SegmentationRegional comparison Key leading countries
Vendor LandscapeVendors covered Vendor classification Market positioning of vendors Competitive scenario
is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at .
View source version on businesswire.com:https://www.businesswire.com/news/home/20180913005413/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY OTHER SCIENCE SCIENCE
SOURCE: Technavio Research
Copyright Business Wire 2018.
PUB: 09/13/2018 07:03 AM/DISC: 09/13/2018 07:03 AM